Terms: = Germ cell tumor AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
27 results:
1. fcgr2b as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis.
Sun Z; Sun X; Yuan Y; Li H; Li X; Yao Z
Medicine (Baltimore); 2023 Sep; 102(37):e35084. PubMed ID: 37713871
[TBL] [Abstract] [Full Text] [Related]
2. An immunosuppressed microenvironment distinguishes lateral ventricle-contacting glioblastomas.
Bartkowiak T; Lima SM; Hayes MJ; Mistry AM; Brockman AA; Sinnaeve J; Leelatian N; Roe CE; Mobley BC; Chotai S; Weaver KD; Thompson RC; Chambless LB; Ihrie RA; Irish JM
JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37192001
[TBL] [Abstract] [Full Text] [Related]
3. Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.
Cheraghlou S; Christensen SR; Leffell DJ; Girardi M
JAMA Dermatol; 2021 May; 157(5):531-539. PubMed ID: 33787836
[TBL] [Abstract] [Full Text] [Related]
4. Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies.
Menyhárt O; Fekete JT; Győrffy B
Carcinogenesis; 2021 Jun; 42(6):804-813. PubMed ID: 33754151
[TBL] [Abstract] [Full Text] [Related]
5. FcγRIIB is a T cell checkpoint in antitumor immunity.
Farley CR; Morris AB; Tariq M; Bennion KB; Potdar S; Kudchadkar R; Lowe MC; Ford ML
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33616086
[TBL] [Abstract] [Full Text] [Related]
6. Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8
Morris AB; Farley CR; Pinelli DF; Adams LE; Cragg MS; Boss JM; Scharer CD; Fribourg M; Cravedi P; Heeger PS; Ford ML
Immunity; 2020 Jan; 52(1):136-150.e6. PubMed ID: 31940267
[TBL] [Abstract] [Full Text] [Related]
7. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
[TBL] [Abstract] [Full Text] [Related]
8. Intraoperative MRI for the management of brain lesions adjacent to eloquent areas.
Reyns N; Leroy HA; Delmaire C; Derre B; Le-Rhun E; Lejeune JP
Neurochirurgie; 2017 Jun; 63(3):181-188. PubMed ID: 28571707
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
Cheng W; Ren X; Zhang C; Cai J; Liu Y; Han S; Wu A
Neurology; 2016 Jun; 86(24):2226-34. PubMed ID: 27225222
[TBL] [Abstract] [Full Text] [Related]
10. Talimogene Laherparepvec for the Treatment of Advanced Melanoma.
Ott PA; Hodi FS
Clin Cancer Res; 2016 Jul; 22(13):3127-31. PubMed ID: 27146699
[TBL] [Abstract] [Full Text] [Related]
11. A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.
Dvorkina M; Nieddu V; Chakelam S; Pezzolo A; Cantilena S; Leite AP; Chayka O; Regad T; Pistorio A; Sementa AR; Virasami A; Barton J; Montano X; Lechertier T; Brindle N; Morgenstern D; Lebras M; Burns AJ; Saunders NJ; Hodivala-Dilke K; Bagella L; De The H; Anderson J; Sebire N; Pistoia V; Sala A; Salomoni P
Clin Cancer Res; 2016 Jul; 22(13):3398-409. PubMed ID: 27076624
[TBL] [Abstract] [Full Text] [Related]
12. Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.
Chan DT; Luk AO; So WY; Kong AP; Chow FC; Ma RC; Lo AW
BMC Endocr Disord; 2016 Feb; 16():12. PubMed ID: 26911576
[TBL] [Abstract] [Full Text] [Related]
13. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract] [Full Text] [Related]
14. Alteration of Electrostatic Surface Potential Enhances Affinity and tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.
Zhao Q; Ahmed M; Guo HF; Cheung IY; Cheung NK
J Biol Chem; 2015 May; 290(21):13017-27. PubMed ID: 25851904
[TBL] [Abstract] [Full Text] [Related]
15. Predictive value of biopsy specimens suspicious for melanoma: support for 6-mm criterion in the ABCD rule.
Soltani-Arabshahi R; Sweeney C; Jones B; Florell SR; Hu N; Grossman D
J Am Acad Dermatol; 2015 Mar; 72(3):412-8. PubMed ID: 25582536
[TBL] [Abstract] [Full Text] [Related]
16. FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study.
Geva R; Vecchione L; Kalogeras KT; Jensen BV; Lenz HJ; Yoshino T; Paez D; Montagut C; Souglakos J; Cappuzzo F; Cervantes A; Frattini M; Fountzilas G; Johansen JS; Høgdall EV; Zhang W; Yang D; Yamazaki K; Nishina T; Papamichael D; Vincenzi B; Macarulla T; Loupakis F; De Schutter J; Spindler KL; Pfeiffer P; Ciardiello F; Piessevaux H; Tejpar S
Gut; 2015 Jun; 64(6):921-8. PubMed ID: 25011934
[TBL] [Abstract] [Full Text] [Related]
17. A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
Wang E; Zhao Y; Monaco A; Uccellini L; Kirkwood JM; Spyropoulou-Vlachou M; Panelli MC; Marincola FM; Gogas H
PLoS One; 2012; 7(7):e40805. PubMed ID: 22911710
[TBL] [Abstract] [Full Text] [Related]
18. Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.
Pinheiro M; Ahlquist T; Danielsen SA; Lind GE; Veiga I; Pinto C; Costa V; Afonso L; Sousa O; Fragoso M; Santos L; Henrique R; Lopes P; Lopes C; Lothe RA; Teixeira MR
BMC Cancer; 2010 Oct; 10():587. PubMed ID: 20979647
[TBL] [Abstract] [Full Text] [Related]
19. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.
Sluijter BJ; van den Hout MF; Stam AG; Lougheed SM; Suhoski MM; van den Eertwegh AJ; van den Tol MP; van Leeuwen PA; Meijer S; Scheper RJ; June CH; de Gruijl TD; Santegoets SJ
Clin Immunol; 2010 Nov; 137(2):221-33. PubMed ID: 20708974
[TBL] [Abstract] [Full Text] [Related]
20. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake.
Benitez-Ribas D; Adema GJ; Winkels G; Klasen IS; Punt CJ; Figdor CG; de Vries IJ
J Exp Med; 2006 Jul; 203(7):1629-35. PubMed ID: 16785312
[TBL] [Abstract] [Full Text] [Related]
[Next]
